Latest "MindBytes BVBA" News Stories
Here are the most relevant search results for "MindBytes BVBA" found in our extensive news archives from over 250 global news sources.
More Information about MindBytes BVBA on BioPortfolio
In addition to our news stories we have dozens of PubMed Articles about MindBytes BVBA for you to read. Along with our medical data and news we also list MindBytes BVBA Clinical Trials, which are updated daily. BioPortfolio also has a large database of MindBytes BVBA Companies for you to search.
Showing "MindBytes BVBA" News Articles, all 4
Cilag collaborates with argenx to develop and commercialise cancer immunotherapy cusatuzumab
Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into a worldwide collaboration and license agreement with argenx BVBA and argenx SE, to develop and commercialize cusatuzumab (ARGX─110).
Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS
PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS Mechelen, Belgium, 6 September 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces its business highlights and financial results for the first half of 2018, prepa...
KBI Biopharma BVBA Launches Belgium Lab Operations
Labs are co-located with JSR Life Sciences’ Amsphere A3 European mfg. site & represent KBI’s first Europe service offerings
KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market
KBI Biopharma, Inc. announced today that its subsidiary KBI Biopharma BVBA has begun operations at its newly completed laboratories in Leuven, Belgium. The laboratories are co-located with JSR Life Sciences’ Amsphere™ A3 European manufacturing site and represent KBI’s first service offering based in Europe. KBI Biopharma BVBA initiated its first clie...
